Hostname: page-component-5c6d5d7d68-wpx84 Total loading time: 0 Render date: 2024-08-18T04:24:47.131Z Has data issue: false hasContentIssue false

Reply to Smyth et al

Published online by Cambridge University Press:  10 May 2016

Ryan A. Maddox*
Affiliation:
Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Lawrence B. Schonberger
Affiliation:
Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Ermias D. Belay
Affiliation:
Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
*
1600 Clifton Road, Mailstop A-30, Atlanta, GA 30333 (rmaddox@cdc.gov).
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
This article is in the public domain, and no copyright is claimed

References

1. Smyth, EG, Farrell, M, Healy, DG, et al. Managing the consequences of neurosurgical intervention in a patient with previously undiagnosed Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol 2014;35:907908 (in this issue).Google Scholar
2. Belay, ED, Blase, J, Sehulster, LM, Maddox, RA, Schonberger, LB. Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob Disease. Infect Control Hosp Epidemiol 2013;34:12711280.Google Scholar
3. Dudzinski, DM, Hébert, PC, Foglia, MB, Gallagher, TH. The disclosure dilemma: large-scale adverse events. N Engl J Med 2010;363:978986.Google Scholar